Home

Latest News

12345678910
Tariffs, Inflation And Tumbling Markets: These 5 ETFs Thrived Amid Last Week's Chaosbenzinga.com
Investor sentiment was shocked by Trump's 25% tariff on auto imports, increasing inflation fears. But some ETFs performed well, with gains up to 22.8%.
Via Benzinga · March 31, 2025
Westwood's New BFRE ETF Prioritizes Democracy Over Autocracybenzinga.com
The Westwood LBRTY Global Equity ETF enables investors to overcome risks linked with economically unstable and corrupt regimes.
Via Benzinga · March 31, 2025
Why Biotech Stocks Like Recursion Pharmaceuticals, CRISPR Therapeutics, and Summit Therapeutics Plunged Todayfool.com
Via The Motley Fool · March 31, 2025
Bitcoin, Ethereum, XRP, Dogecoin Flatline As Markets Brace For Impact Of Trump Tariffsbenzinga.com
Cryptocurrency markets are trading in a tight sideways range on Monday as markets expect the impact of tariff announcements on Wednesday.
Via Benzinga · March 31, 2025
Out Of Nowhere: Can BigTech's Antitrust Troubles Disrupt FinTech?benzinga.com
Via Benzinga · March 31, 2025
P/E Ratio Insights for Herc Holdingsbenzinga.com
Via Benzinga · March 31, 2025
Shell Unusual Options Activitybenzinga.com
Via Benzinga · March 31, 2025
Review Of Market Concentration in the European ETF Industry At The Classification Leveltalkmarkets.com
ETFs classified as Equity U.S. held 26.83% of the overall assets under management at the end of December 2024.
Via Talk Markets · March 31, 2025
UPS Offers 'Peace Of Mind With No Surprises' With Transparent Tariff Cost Toolbenzinga.com
With tariffs coming for more countries in various amounts, a new tool from UPS could help global consumers know the increased prices better.
Via Benzinga · March 31, 2025
Looking Into Workday's Recent Short Interestbenzinga.com
Via Benzinga · March 31, 2025
Is Edison Intl Gaining or Losing Market Support?benzinga.com
Via Benzinga · March 31, 2025
Peering Into PNC Financial Services Gr's Recent Short Interestbenzinga.com
Via Benzinga · March 31, 2025
Sabra Healthcare REIT Stock Gets RS Rating Upgradeinvestors.com
Sabra Healthcare REIT stock now clears the 80 or higher Relative Strength Rating threshold, with a jump from 78 to 82 Monday.
Via Investor's Business Daily · March 31, 2025
Shoptalk 2025: Goldman Sachs Analyst Unveils Insights On AI, Video, Retail And Stock Picksbenzinga.com
Goldman Sachs analyst shares key takeaways from 2025 Shoptalk Conference, highlighting conversational and personalized eCommerce, critical video content, and the role of AI in improving brand experience.
Via Benzinga · March 31, 2025
Peter Schiff Sounds The Alarm: 'Same Mistake Again' Could Trigger Economic Firestormbenzinga.com
Investors should prepare for a 2008-style crisis.Benzinga warns of potential economic crisis predicted by Peter Schiff in 2008. Tariffs, rising interest rates, misguided Fed policy may cause trouble.
Via Benzinga · March 31, 2025
Vertex Discontinues Development Of Type 1 Diabetes Candidate After Disappointing Databenzinga.com
Vertex halts VX-264 trials after missing efficacy goals but continues advancing zimislecel, a potential treatment for severe type 1 diabetes, toward approval.
Via Benzinga · March 31, 2025
Stryker Stock Gets Relative Strength Rating Liftinvestors.com
In a welcome move, Stryker stock saw its Relative Strength Rating improve to 72 on Monday, up from 69 a day earlier.
Via Investor's Business Daily · March 31, 2025
Corcept Therapeutics Stock Jumps On Upbeat Ovarian Cancer Trial Data, Analysts Boost Price Forecastbenzinga.com
Corcept's ROSELLA trial met its primary endpoint, showing relacorilant improved progression-free and overall survival in platinum-resistant ovarian cancer.
Via Benzinga · March 31, 2025
11 Analysts Have This To Say About DocuSignbenzinga.com
Via Benzinga · March 31, 2025
Decoding AbbVie's Options Activity: What's the Big Picture?benzinga.com
Via Benzinga · March 31, 2025
A Closer Look at Atlassian's Options Market Dynamicsbenzinga.com
Via Benzinga · March 31, 2025
Beyond The Numbers: 30 Analysts Discuss Snowflake Stockbenzinga.com
Via Benzinga · March 31, 2025
Procter & Gamble Options Trading: A Deep Dive into Market Sentimentbenzinga.com
Via Benzinga · March 31, 2025
The Analyst Verdict: Sea In The Eyes Of 7 Expertsbenzinga.com
Via Benzinga · March 31, 2025
Where Varonis Systems Stands With Analystsbenzinga.com
Via Benzinga · March 31, 2025
What 13 Analyst Ratings Have To Say About Baker Hughesbenzinga.com
Via Benzinga · March 31, 2025
Breaking Down Payoneer Global: 6 Analysts Share Their Viewsbenzinga.com
Via Benzinga · March 31, 2025
Nano-X Imaging (NNOX) Q4 2024 Earnings Call Transcriptfool.com
NNOX earnings call for the period ending December 31, 2024.
Via The Motley Fool · March 31, 2025
The trading volume of these stocks is deviating from the norm in today's session.chartmill.com
In today's session, these stocks are experiencing unusual volume.
Via Chartmill · March 31, 2025
Virax Biolabs' Investigational Diagnostic Tests Has An Attractive Market Opportunity', Analyst Initiates With Buy Ratingbenzinga.com
Virax Biolabs' T-cell testing platform targets post-viral syndromes like Long COVID. HC Wainwright sees a major market opportunity, setting a $3 price target.
Via Benzinga · March 31, 2025
Growth Or Value? Allspring's New ETFs Offer Bothbenzinga.com
Allspring Global Investments launched two new actively managed ETFs (AGR, ASLV) to provide investors with access to mispriced stocks and value ideas.
Via Benzinga · March 31, 2025
Tom Lee Sees 'Right Pieces' For A Market Bottom: 'Investors Are A Little Too Scared Heading Into Wednesday'benzinga.com
Investors continue to brace for volatility ahead of U.S. President Donald Trump's tariff announcement this week. Fundstrat's Tom Lee believes bullish traders will get rewarded.
Via Benzinga · March 31, 2025
Why Is Corcept (CORT) Stock Soaring Today
Shares of biopharma company Corcept Therapeutics (NASDAQ:CORT) jumped 94.9% in the afternoon session after the company announced that its Phase 3 trial (ROSELLA) met its goal of improving progression-free survival and overall survival in treating resistant ovarian cancer with a new therapy (a combination of Relacorilant and Nab-paclitaxel). 
Via StockStory · March 31, 2025
Trump Family Tightens Grip On DeFi Platform World Liberty Financialbenzinga.com
The Trump family has significantly increased its control over World Liberty Financial, a decentralized finance platform still under development.
Via Benzinga · March 31, 2025
Okta's Options Frenzy: What You Need to Knowbenzinga.com
Via Benzinga · March 31, 2025
A Closer Look at Delta Air Lines's Options Market Dynamicsbenzinga.com
Via Benzinga · March 31, 2025
Spotlight on PayPal Holdings: Analyzing the Surge in Options Activitybenzinga.com
Via Benzinga · March 31, 2025
Here’s The Good News – Stocks Getting Closetalkmarkets.com
Bonds rallied and yields fell not because of inflation and certainly not because of tariffs. It goes back to the growth scare.
Via Talk Markets · March 31, 2025
Congressman Buys Up To $600K In Bitcoin ETF After Selling $1 Million In Goldman Sachs Stock: Committee Assignment Could Be Red Flagbenzinga.com
A Congressman who bought shares of a Bitcoin (CRYPTO: BTC) ETF before President Donald Trump announced an Executi
Via Benzinga · March 31, 2025
Gold Rally Could Gain Momentum With Central Bank Buying And China Allocation, Analyst Saysbenzinga.com
Gold prices exceeded $3,000/oz, with potential to reach $3,500 if investment demand rises. China's insurance sector and central banks may increase gold holdings, while ETF inflows signal growing retail interest. Trade policy uncertainty and a weaker U.S. dollar could further support prices.
Via Benzinga · March 31, 2025
Semiconductor Sector Hit Hard as Hedge Funds Retreat from Techtalkmarkets.com
Hedge funds are rapidly reducing their investments in global technology stocks, particularly in the semiconductor industry.
Via Talk Markets · March 31, 2025
Bulls Have A Lot To Prove In Q2talkmarkets.com
The energy sector has been running the table year-to-date. Interestingly, the price of crude oil hasn’t participated much in this rally with the energy sector.
Via Talk Markets · March 31, 2025
Google's New AI Travel Features Could Drive Major Growth In Search Volume: Analystbenzinga.com
On March 27, Alphabet Inc (NASDAQ:GOOG) (NASDAQ:GOOGL) Google introduced several new features across Search, Maps, and Gemini
Via Benzinga · March 31, 2025
FDA Approves AstraZeneca's Imfinzi As First Perioperative Immunotherapy For Muscle-Invasive Bladder Cancer Patientsbenzinga.com
FDA approved AstraZeneca's Imfinzi regimen for muscle-invasive bladder cancer, while the EU backed Calquence combo for untreated mantle cell lymphoma.
Via Benzinga · March 31, 2025
Arm Holdings Reportedly Aims To Capture Half Of The Data Center CPU Market In 2025 – Retail’s Divided As Stock Fallsstocktwits.com
The surge in Arm's data center presence is fueled by the rapid expansion of artificial intelligence, Mohamed Awad, the company’s infrastructure chief, told Reuters.
Via Stocktwits · March 31, 2025
Exploring the top movers within the S&P500 index during today's session.chartmill.com
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Monday.
Via Chartmill · March 31, 2025
Monday's session: top gainers and loserschartmill.com
Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via Chartmill · March 31, 2025
Softs Report - Monday, March 31content/com
FCOJ closed lower and kept the down trends in prices intact. Chart trends are down again on the daily charts.
Via Talk Markets · March 31, 2025
Hut 8 Shares Are Down Today: What's Going On?benzinga.com
Hut 8 Corp. (NASDAQ: HUT) shares are are trading lower Monday potenafter the company announced it is spinning off its Bitcoin mining operations into a new entity, American Bitcoin, in partnership with Eric Trump.
Via Benzinga · March 31, 2025
AMD Powers Oracle Cloud With New Epyc Chips Promising Major Boost In Performancebenzinga.com
AMD announced its fifth-generation EPYC processors power OCI Compute E6 shapes, delivering up to 2x better cost to performance. Stock down 45% in past year.
Via Benzinga · March 31, 2025